Skip to main content

16-01-2015 | Non-small-cell lung cancer | Article

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Bradley JD et al. Lancet Oncol 2015; 16(2):187-99. doi:10.1016/S1470-2045(14)71207-0

Please log in to get access to this content

Related topics